SGHT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Sight Sciences Inc (SGHT) does not present a compelling buy opportunity for a beginner, long-term investor at this time. The technical indicators show a bearish trend, insider selling is significantly high, and the company's financial performance in the latest quarter reflects declining revenue and net income. While analysts have shown optimism with increased price targets and positive outlooks for 2026, the lack of immediate catalysts, weak trading sentiment, and no proprietary trading signals suggest holding off on investment for now.
The MACD histogram is negative and expanding, indicating bearish momentum. RSI is neutral at 22.527, and moving averages are converging, showing no clear trend. The stock is trading near its key support level of 5.468, with resistance at 6.438.
Gross margin has improved YoY, indicating operational efficiency.
Insider selling has increased by 4122.05% over the last month, signaling potential lack of confidence from insiders. The company's financials show declining revenue (-1.25% YoY) and net income (-26.18% YoY). No recent news or significant trading trends from hedge funds.
In Q3 2025, revenue dropped to $19.91M (-1.25% YoY), net income declined to -$8.17M (-26.18% YoY), and EPS fell to -0.16 (-27.27% YoY). Gross margin improved to 88.9% (+5.98% YoY).
Analysts are optimistic about the company's long-term prospects, with several firms raising price targets (e.g., UBS to $12, Piper Sandler to $9). However, some caution remains due to near-term challenges, and the stock is still rated Neutral by Citi and Equal Weight by Morgan Stanley.
